WASHINGTON, Feb. 28 -- Sen. Jon Ossoff issued the following press release: U.S. Senator Jon Ossoff today released the following statement. "Eight months ago, Donald Trump lied to the country when he... Read More
WASHINGTON, Feb. 28 -- Sen. Patty Murray issued the following press release: Today, U.S. Senator Patty Murray (D-WA), Vice Chair of the Senate Appropriations Committee, issued the following statement... Read More
WASHINGTON, Feb. 28 -- Sen. Chris Murphy issued the following press release: U.S. Senator Chris Murphy (D-Conn.) released the following statement in response to Donald Trump launching an illegal war ... Read More
WASHINGTON, Feb. 28 -- Sen. Jeff Merkley issued the following press release: Following President Trump's unconstitutional strikes against Iran, Oregon's U.S. Senator Jeff Merkley-a senior member of t... Read More
U.S., Feb. 28 -- ClinicalTrials.gov registry received information related to the study (NCT07435181) titled 'Comparative Outcomes of Radiofrequency Ablation of Concealed and Manifest Accessory Pathway... Read More
U.S., Feb. 28 -- ClinicalTrials.gov registry received information related to the study (NCT07434739) titled 'PAravertebral CaTheter Versus Epidural Analgesia in Totally Minimally Invasive Esophagectom... Read More
U.S., Feb. 28 -- ClinicalTrials.gov registry received information related to the study (NCT07436065) titled 'Sterile vs Clean Non-Sterile Wound Dressing in Orthopedic Surgery' on Feb. 12. Brief Summa... Read More
U.S., Feb. 28 -- ClinicalTrials.gov registry received information related to the study (NCT07440316) titled 'Colorado Community Engagement Alliance' on Feb. 10. Brief Summary: The Colorado Community ... Read More
U.S., Feb. 28 -- ClinicalTrials.gov registry received information related to the study (NCT07439055) titled 'Real-World Joint Outcomes After Selective Transition to Low-Dose Emicizumab in Pediatric He... Read More
U.S., Feb. 28 -- ClinicalTrials.gov registry received information related to the study (NCT07437534) titled 'Comparative Evaluation of the Safety and Effectiveness of Crisaborole Ointment (2%) Versus ... Read More